(Rac)-Zevaquenabant [CAS 1610420-28-4] (10mM in DMSO)
Partner: MedChemexpress LLC
| CAS No: | 1610420-28-4 |
| Applications: | COVID-19-immunoregulation |
| MW: | 547.98 |
| Formula: | C25H21ClF3N5O2S |
| SMILES: | O=S(/N=C(N1N=C(C2=CC=C(Cl)C=C2)C(C3=CC=CC=C3)C1)/N=C(N)/C)(C4=CC=C(C(F)(F)F)C=C4)=O |
| Purity: | 99.05 |
| Description: | (Rac)-Zevaquenabant ((Rac)-MRI-1867, compound 6b) is a cannabinoid receptor type 1 (CB1R)/iNOS antagonist, with a Ki of 5.7 nM for CB1R. (Rac)-Zevaquenabant is potential for the research of liver fibrosis[1]. |
| Shipping Conditions: | Ship on cold packs |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
